News
Our Drug Development Activities Featured on NHK World News
We are pleased to announce that our drug development activities were featured on NHK World News, broadcast on January 30, 2026.
The broadcast focused on the development of Taiwan’s biotechnology industry and related drug development initiatives through collaboration between Japan and Taiwan.
Through internationally collaborative research, we are developing drugs for a wide range of diseases, including anti-aging/longevity and cancer. In Taiwan, we are collaborating with Taipei Medical University (TMU) to promote joint research and development of the PAI-1 inhibitor RS5614 and artificial intelligence (AI)-based programmed medical devices (announced on August 30 and November 5, 2024, and December 15, 2025).
The broadcast news introduced the specifics of the drug development being carried out jointly by our company and Taipei Medical University.
NHK World News HP
https://www3.nhk.or.jp/nhkworld/en/news/videos/20260130145547829/
YouTube
https://www.youtube.com/watch?v=APju90xMvvg
Related links
“Announcement of the joint R&D collaboration agreement for artificial intelligence (AI)-based software as a medical device (SaMD) with Taipei Medical University (TMU)-Biotech Co., Ltd.” (Disclosed on August 30, 2024)
https://www.renascience.co.jp/wp-content/uploads/2024/11/24-0830Announcement-of-the-joint-RD-collaboration-agreement-for-artificial-intelligence-AI-based-software-as-a-medical-device-SaMD-.pdf
“Notice of the completion of a joint development agreement with Taipei Medical University (TMU)-Biotech Co. Ltd. (Taipei) for the PAI-1 inhibitor RS5614.” (Disclosed on November 5, 2024)
https://www.renascience.co.jp/wp-content/uploads/2024/11/Notice-of-the-completion-of-a-joint-development-agreement-with-Taipei-Medical-University-1.pdf
“Announcement of initiation of a Phase III bridging study for unresectable melanoma in Taiwan.” (Disclosed on December 15, 2025)
https://www.renascience.co.jp/wp-content/uploads/2025/12/Phase-III-Melanoma-Bridging-Study-Initiation.pdf